iMedix Medical Content Engine 3.13.37

Apcalis SX: Uses, Dosage & Safety Information

Apcalis SX

Apcalis SX

Tadalafil
No oral jelly dosage form exists in the FDA drug registry for any medicine. The oral gels that are registered carry benzocaine, fluoride and diphenhydramine — drugs designed to act in the mouth rather than be absorbed. Registered tadalafil exists in six forms including an oral suspension, and none of them is a gel.
  • ActiveIngredient: Tadalafil
  • DosageForm: Oral jelly
  • Dosage: 20 mg
  • Indications: Erectile dysfunction
  • Manufacturer: Ajanta Pharma Ltd
  • Storage: Store below 30°C
  • Drug Status: Not Approved

What is Apcalis SX?

No oral jelly exists as a registered dosage form for any medicine. The oral gels in the FDA registry carry benzocaine, fluoride and diphenhydramine — drugs designed to act inside the mouth rather than be absorbed. Tadalafil is registered in six forms, including an approved oral suspension, and none of them is a gel.

No oral jelly exists as a registered dosage form — for any medicine
The FDA drug registry contains no products at all under an oral jelly dosage form. The oral gels that do exist are benzocaine, fluoride and diphenhydramine.
Every one of those is designed to act in the mouth and not to be absorbed — a numbing gel, a dental fluoride, a throat preparation. The format is borrowed from products whose entire purpose is the opposite of what a systemic drug needs.

No product under this name appears in FDA labelling, Drugs@FDA, the drug registry or the adverse event database.3

Registered tadalafil comes in six forms, and a jelly is not among them: film-coated tablet, plain tablet, coated tablet, capsule, granule and oral suspension.

Listed under erectile dysfunction. The approved oral forms of tadalafil, and the doses they come in, are set out under tadalafil’s registered presentations.

How to Take Apcalis SX

There is no approved way to take it

No product under this name appears in FDA labelling, Drugs@FDA, the National Drug Code Directory or the adverse event database, so there are no FDA-reviewed directions for it.3

If swallowing tablets is the difficulty

Tell a prescriber. It changes what can be offered, and an approved tadalafil oral suspension exists.5

How approved tadalafil is taken

Approved tadalafil tablets for erectile dysfunction are taken as needed before sexual activity, no more than once a day, or once daily at a low dose, with or without food; they are not split.4

Storage

Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). Keep it out of the reach of children.4

What not to do

Do not assume a jelly acts faster or can be divided into reliable doses; nothing establishes either. If a sachet seems to do nothing, do not take another on the same day.24

What Are the Side Effects of Apcalis SX?

No profile can be published for a format whose delivered dose and remaining potency are both unestablished.3

Two Uncertainties a Sachet Adds
UncertaintyWhy the format creates itConsequence
How much was takenContents remain in the sachet and in the mouthDose varies between uses by the same person
How much is still activeA drug dispersed in water degrades differently from one pressed dryPotency depends on age and storage, neither specified
Blood-pressure fallAdditive with nitrates, alpha-blockers and antihypertensivesMagnitude unpredictable in both directions
Repeat dosingA weak effect invites taking another sachetTwo unknown amounts close together

Source: 42

The effects tadalafil itself produces — headache, back pain, dyspepsia, nasal congestion, flushing — are documented on the the tadalafil reference product page. What this format changes is not which of them occur but how predictably.

Emergency – seek care
  • Chest pain — and say you have taken tadalafil, whatever the packaging called it
  • An erection lasting more than four hours
  • Sudden loss of vision or hearing
  • Fainting or severe dizziness

What is Apcalis SX Used For?

No approved use. The claim behind the format is that a jelly is easier to take and works faster, and both halves are worth examining.3

What oral gels are actually for

Registered Oral Gels
IngredientProductsWhere it is meant to act
Benzocaine56In the mouth — numbing gums and ulcers
Sodium fluoride12On the tooth surface
Stannous fluoride11On the tooth surface
Diphenhydramine8In the mouth — local relief
Any systemically absorbed drug0—

Source: 1

The pattern is not an accident of the market. A gel holds a drug against mucosa, which suits something meant to stay there and works against something meant to be swallowed, survive the stomach and be absorbed further down.

The genuine wish, and where it is already met

Wanting something other than a tablet is reasonable, and tadalafil does exist as a registered liquid: an oral suspension, approved and marketed, though for pulmonary arterial hypertension rather than for erectile dysfunction.2

That is the difference between a reformulation and a repackaging. A suspension was developed, tested and approved as a liquid; a jelly sachet asserts the same convenience without any of that work behind it.

Interactions Alcohol:

Consult your doctor
No assessment is possible when the delivered dose varies between uses. If tadalafil is present, alcohol adds to its blood-pressure lowering.

Interactions Other Medications:

Unsafe
Organic nitrates and guanylate cyclase stimulators are absolute contraindications with tadalafil and hold in any format. The alpha-blocker and CYP3A4 rules are dose limits, and a sachet has no fixed dose to apply them to.

Special Groups Pregnancy:

Unsafe
Not applicable — the molecule is approved only in men for this indication.

Special Groups Breastfeeding:

Unsafe
Not applicable to the approved indications.

Special Groups Elderly:

Unsafe
Older men both find tablets harder to swallow and take more medicines managed by dose — the group most drawn to this format and least suited to it.

Special Groups Children:

Unsafe
No approved paediatric use exists for tadalafil in this indication.

Effects on Activities Driving:

Consult your doctor
Unknown. The delivered dose varies with how the sachet is emptied, so the degree of dizziness cannot be anticipated.

Effects on Activities Operating Machinery:

Consult your doctor
Unknown, for the same reason.

No FDA record of any kind exists for this product.3

The concern is that the format looks like innovation and is closer to the reverse. Oral gels exist in the registry, and every one of them carries a drug intended to stay in the mouth: benzocaine for numbing, fluoride for teeth, diphenhydramine for local relief. Holding a drug against mucosa is what a gel is good at, and it is the opposite of what a systemically acting medicine requires.

The underlying wish is legitimate. People dislike tablets, and a liquid tadalafil exists and is approved — as an oral suspension with a stated concentration, a shelf life and storage conditions, all established by testing. That product shows the problem is solvable and what solving it involves.

A sachet without an approval has taken the convenience and left the work. The result is a dose that varies with how thoroughly the sachet is emptied and a potency that depends on how long it has been in a warm shipping container.

Critical Warnings for Apcalis SX Use

The format has no registered precedent

No oral jelly exists as a dosage form in the FDA registry, for tadalafil or for anything else. The oral gels that do exist deliver drugs meant to act in the mouth rather than be absorbed.

A sachet cannot be titrated

Tadalafil for erectile dysfunction is adjusted between 5 and 20 mg by response. A single-dose sachet delivers what it delivers, and no registered strength exists to compare it against.

Liquid formulations degrade differently

Water-containing preparations have shorter shelf lives and tighter storage requirements than tablets. Neither is specified here, so remaining potency cannot be assumed.

The contraindications are unaffected

Organic nitrates in any form and guanylate cyclase stimulators such as riociguat remain absolute bars with tadalafil, in any format.

Source: 124

Nitrates

Tadalafil is contraindicated with any organic nitrate because it potentiates their blood-pressure-lowering effect.4

Guanylate cyclase stimulators

Tadalafil is contraindicated with guanylate cyclase stimulators such as riociguat.4

Tadalafil hypersensitivity

Contraindicated after a serious hypersensitivity reaction to tadalafil.4

See Interactions.

Dosage

A sachet cannot be divided
Tadalafil for erectile dysfunction is titrated between 5 and 20 mg according to response and tolerability. A single-dose sachet delivers whatever it contains, and no registered strength exists to check that against.43
Registered Tadalafil Forms
Dosage formRegistered products
Tablet, film coated181
Tablet77
Tablet, coated9
Capsule1
Granule1
Suspension1
Gel or jelly0

Source: 2

▶Clinical detailstechnical detail

A semi-solid format raises two problems that a tablet does not have. The first is dose delivery: some of the contents remain in the sachet and in the mouth, and how much varies with how thoroughly it is emptied and swallowed. The second is stability — a gel contains water, and a drug dispersed in water degrades on a different timescale from one compressed dry into a tablet, which is why liquid formulations carry shorter shelf lives and tighter storage conditions.

Both are solvable, and the approved oral suspension of tadalafil shows they have been solved for this molecule: that product specifies its concentration, its storage and its shelf life because each was established by testing. A sachet without an approval has inherited the problems without the work, and the practical consequence is that neither the delivered dose nor the remaining potency can be stated.24

Kidney and Liver Limits
FormulationActive IngredientsClinical Note
Renal impairmentTadalafilApproved labelling lowers or caps doses; a fixed sachet cannot follow those limits
Hepatic impairmentTadalafilApproved labelling caps as-needed doses in mild or moderate impairment and advises against use in severe impairment

Source: 4

What Does Apcalis SX Interact With?

The interacting substances are those of tadalafil; with a sachet of unknown content, the dose limits the labelling sets for some combinations cannot be applied reliably.4

Interactions by Severity
Interacting SubstanceEffect and RiskSeverityDocumentation
Organic nitrates, including nitroglycerinSevere fall in blood pressureContraindicatedExcellent — labelled contraindication
Guanylate cyclase stimulators such as riociguatLow blood pressureContraindicatedExcellent — labelled contraindication
Strong CYP3A4 inhibitors such as ketoconazole and ritonavirHigher tadalafil exposure; labelled dose caps applyMajorExcellent — labelled interaction
Alpha-blockers, other blood pressure medicines, alcoholAdditive fall in blood pressureModerateGood — labelled interaction
CYP3A4 inducers such as rifampinLower tadalafil exposureMinorGood — labelled interaction

Source: 4

No such dosage form exists in the FDA registry, for tadalafil or anything else. The oral gels that are registered carry benzocaine, fluoride and diphenhydramine — drugs meant to act in the mouth rather than be absorbed.
Nothing establishes that. Tadalafil is valued for lasting up to 36 hours rather than for speed of onset, so a faster format addresses a property this drug was never chosen for.
Tadalafil is titrated between 5 and 20 mg by response. A sachet delivers whatever comes out of it, and how much stays behind in the packet and the mouth varies each time.
Raise it with a prescriber — it changes what can be offered. Registered liquid tadalafil exists as an oral suspension, developed and tested as a liquid, with a stated concentration and storage conditions.
Absolutely, and regardless of dose. Format affects how intensely a drug acts; it does not touch the absolute prohibitions, which belong to the molecule.

Evidence scope

What we know
  • No oral jelly dosage form exists in the FDA drug registry for any medicine.
  • Registered oral gels carry benzocaine, fluoride and diphenhydramine — drugs meant to act in the mouth.
  • Tadalafil is registered in six dosage forms, including one oral suspension; none is a gel or jelly.
What remains uncertain
  • What a sachet sold under this name contains and how much of it is swallowed.
  • How long the preparation retains its potency, and under what storage.
  • Whether anyone has been harmed. A sachet that lost potency in transit produces no symptom to describe, so the commonest failure of this format generates nothing a reporting system could receive.

Source: 123

What has been reported to the FDA

Nothing under this name at the 30 July 2026 data cut.3

Why a degraded sachet leaves no trace

An empty result records that nobody filed under this name, not that nothing happened.

Population note: loss of potency is the failure this format is most prone to and the one least likely to be reported. A preparation that has degraded in transit simply does not work, and a man who concludes the product is ineffective tells a seller at most. Degradation also produces no distinctive symptom to report — there is nothing to describe except absence of effect. A database of adverse events is structurally blind to a medicine that has quietly stopped being one.

Who was this medicine studied in?

No one. A semi-solid formulation requires its own testing for content, delivery and stability, and none has been submitted for any product under this name.

Who this is and is not appropriate for

No one, on the available evidence. The contraindications of tadalafil apply in any format, and neither the dose nor the potency of a sachet can be established.4

Someone who finds tablets difficult has a real conversation to have with a prescriber, and registered liquid tadalafil exists to make it a practical one.

Where to report and verify

Routing to Official Registries
What you needWhere to go
Report a side effectFDA MedWatch
Pregnancy-specific dataMotherToBaby
Full prescribing informationDailyMed
Verify a pharmacy websiteFDA BeSafeRx · LegitScript

References

  1. FDA National Drug Code Directory — products with an oral route, grouped by dosage form and ingredient
    Directory accessed 2026-09-23
    Used for: the absence of any oral jelly dosage form, and the composition of the registered oral gel market led by benzocaine, sodium and stannous fluoride and diphenhydramine.
    accessdata.fda.gov — NDC Directory
  2. FDA National Drug Code Directory — tadalafil products by dosage form
    Directory accessed 2026-09-23
    Used for: the six registered tadalafil forms, including the approved oral suspension, and the absence of a gel or jelly presentation.
    accessdata.fda.gov — NDC Directory
  3. openFDA — labelling, Drugs@FDA and FAERS queries for APCALIS
    Data cut 2026-07-30 · Accessed 2026-09-23
    Used for: the absence of any application, product code, labelling or adverse event record under this brand name.
    open.fda.gov — drug adverse event API
  4. FDA Prescribing Information, CIALIS (tadalafil) — Sections 2.1, 4.1 and 16 Storage
    Revised 2026-06 · Accessed 2026-09-23
    Used for: the titration range for erectile dysfunction, the nitrate contraindication, and the storage conditions against which a water-containing preparation is compared.
    dailymed.nlm.nih.gov — CIALIS SPL
  5. Drugs@FDA — approved tadalafil oral suspension
    Records accessed 2026-09-23
    Used for: the existence of a developed and tested liquid tadalafil, cited as the answer to the difficulty this format claims to solve.
    accessdata.fda.gov — Drugs@FDA

How this page was sourced

The absence of an oral jelly form is a query result from the FDA registry rather than an inference from silence, and the ingredients that do appear in oral gels are listed so the pattern can be judged rather than taken on trust.

The approved suspension is cited because it shows the underlying problem is solvable and what solving it involved — a stated concentration, storage conditions and a shelf life, each established by testing.

Nothing is asserted about what a sachet sold under this name contains or how much of it is swallowed.

Review cycle. Clinical review completed 28 September 2026. Next review due by 28 September 2027, or earlier if the labelling is revised.

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.